13 commercial payer policies list 96374. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
13 policies from 5 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 96374 |
|---|---|---|
| Chelation Therapy for Off-Label Uses | Sep 1, 2025 | Covered |
| Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric Disorders | Jan 1, 2026 | Covered |
| Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease | Dec 15, 2025 | Covered |
| Policy | Effective | Status of 96374 |
|---|---|---|
| Chelation Therapy for Off-Label Uses | Sep 1, 2025 | Covered |
| Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric Disorders |
|---|
| Jan 1, 2026 |
| Covered |
| Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease | Dec 15, 2025 | Covered |
|---|
| Policy | Effective | Status of 96374 |
|---|---|---|
| Chelation Therapy for Off-Label Uses | Sep 1, 2025 | Covered |
| Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric Disorders | Jan 1, 2026 | Covered |
| Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease | Dec 15, 2025 | Covered |
| Policy | Effective | Status of 96374 |
|---|---|---|
| Chelation Therapy for Off-Label Uses | Sep 1, 2025 | Covered |
| Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric Disorders | Jan 1, 2026 | Covered |
| Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease | Dec 15, 2025 | Covered |
| Policy | Effective | Status of 96374 |
|---|---|---|
| Aldesleukin (Proleukin) | Sep 21, 2023 | Covered |